{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:42:26Z","timestamp":1793396546849,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016147","name":"Korean Association for the Study of the Liver","doi-asserted-by":"publisher","award":["KASLKLF2019-0"],"award-info":[{"award-number":["KASLKLF2019-0"]}],"id":[{"id":"10.13039\/501100016147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00535-023-01999-4","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T12:03:48Z","timestamp":1684325028000},"page":"682-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-6407","authenticated-orcid":false,"given":"Kyung-Ah","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Hyang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"1999_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570\u201380.","journal-title":"N Engl J Med"},{"key":"1999_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2020.0028","volume":"27","author":"A Tanaka","year":"2021","unstructured":"Tanaka A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol. 2021;27:1\u201321.","journal-title":"Clin Mol Hepatol"},{"key":"1999_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/jgh.15329","volume":"36","author":"T Lv","year":"2021","unstructured":"Lv T, Chen S, Li M, et al. Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36:1423\u201334.","journal-title":"J Gastroenterol Hepatol"},{"key":"1999_CR4","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70:1989\u20132003.","journal-title":"Gut"},{"key":"1999_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Mori M, Matsumoto K, et al. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res. 2019;49:881\u20139.","journal-title":"Hepatol Res"},{"key":"1999_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.29717","volume":"67","author":"CF Murillo Perez","year":"2018","unstructured":"Murillo Perez CF, Goet JC, Lammers WJ, et al. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history. Hepatology. 2018;67:1920\u201330.","journal-title":"Hepatology"},{"key":"1999_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms MH, van Buuren HR, Corpechot C, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71:357\u201365.","journal-title":"J Hepatol"},{"key":"1999_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","volume":"16","author":"M Lu","year":"2018","unstructured":"Lu M, Zhou Y, Haller IV, et al. Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment. Clin Gastroenterol Hepatol. 2018;16:1342-50.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1999_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/apt.13448","volume":"43","author":"KA Kim","year":"2016","unstructured":"Kim KA, Ki M, Choi HY, et al. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther. 2016;43:154\u201362.","journal-title":"Aliment Pharmacol Ther"},{"key":"1999_CR10","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2016","unstructured":"Cheol Seong S, Kim Y-Y, Khang Y-H, et al. Data resource profile: the national health information database of the national health insurance service in South Korea. Int J Epidemiol. 2016;46:799\u2013800.","journal-title":"Int J Epidemiol"},{"key":"1999_CR11","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1345\/aph.1H018","volume":"40","author":"LM Hess","year":"2006","unstructured":"Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280\u20138.","journal-title":"Ann Pharmacother"},{"key":"1999_CR12","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2337\/diacare.27.9.2149","volume":"27","author":"DT Lau","year":"2004","unstructured":"Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149\u201353.","journal-title":"Diabetes Care"},{"key":"1999_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335\u201351.","journal-title":"Stat Med"},{"key":"1999_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s12072-019-09984-x","volume":"13","author":"N Zeng","year":"2019","unstructured":"Zeng N, Duan W, Chen S, et al. Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hep Intl. 2019;13:788\u201399.","journal-title":"Hep Intl"},{"key":"1999_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-021-01836-6","volume":"57","author":"K Matsumoto","year":"2022","unstructured":"Matsumoto K, Ohfuji S, Abe M, et al. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case\u2013control study. J Gastroenterol. 2022;57:19\u201329.","journal-title":"J Gastroenterol"},{"key":"1999_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/hepr.13586","volume":"51","author":"M Takamura","year":"2021","unstructured":"Takamura M, Matsuda Y, Kimura N, et al. Changes in disease characteristics of primary biliary cholangitis: an observational retrospective study from 1982 to 2016. Hepatol Res. 2021;51:166\u201375.","journal-title":"Hepatol Res"},{"key":"1999_CR17","doi-asserted-by":"publisher","first-page":"25906","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo A, Jepsen P, Morenghi E, et al. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep. 2016;6:25906.","journal-title":"Sci Rep"},{"key":"1999_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"1999_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930\u201350.","journal-title":"Hepatology"},{"key":"1999_CR20","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149:1804-12.e4.","journal-title":"Gastroenterology"},{"key":"1999_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/hep.31776","volume":"74","author":"BV John","year":"2021","unstructured":"John BV, Aitcheson G, Schwartz KB, et al. Male sex is associated with higher rates of liver-related mortality in primary biliary cholangitis and cirrhosis. Hepatology. 2021;74:879\u201391.","journal-title":"Hepatology"},{"key":"1999_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","volume":"144","author":"M Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144:560-569.e7.","journal-title":"Gastroenterology"},{"key":"1999_CR23","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.cgh.2018.12.028","volume":"17","author":"AC Cheung","year":"2019","unstructured":"Cheung AC, Lammers WJ, Murillo Perez CF, et al. Effects of age and sex of response to ursodeoxycholic acid and transplant-free Survival in patients with primary biliary cholangitis. Clin Gastroenterol Hepatol. 2019;17:2076-84.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1999_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32426","author":"SB Roberts","year":"2022","unstructured":"Roberts SB, Hirschfield GM, Worobetz LJ, et al. Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis. Hepatology. 2022. https:\/\/doi.org\/10.1002\/hep.32426.","journal-title":"Hepatology"},{"key":"1999_CR25","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/hep.26176","volume":"57","author":"K Harada","year":"2013","unstructured":"Harada K, Hirohara J, Ueno Y, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology. 2013;57:1942\u20139.","journal-title":"Hepatology"},{"key":"1999_CR26","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","volume":"66","author":"Y Natarajan","year":"2021","unstructured":"Natarajan Y, Tansel A, Patel P, et al. Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis. Dig Dis Sci. 2021;66:2439\u201351.","journal-title":"Dig Dis Sci"},{"key":"1999_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"65","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Lammers WJ, van Buuren HR, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;65:321\u20139.","journal-title":"Gut"},{"key":"1999_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/flgastro-2020-101713","volume":"13","author":"M Sivakumar","year":"2022","unstructured":"Sivakumar M, Gandhi A, Shakweh E, et al. Widespread gaps in the quality of care for primary biliary cholangitis in UK. Frontline Gastroenterol. 2022;13:32\u20138.","journal-title":"Frontline Gastroenterol"},{"key":"1999_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12876-020-01219-w","volume":"20","author":"NL Allard","year":"2020","unstructured":"Allard NL, MacLachlan JH, Dev A, et al. Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes. BMC Gastroenterol. 2020;20:140.","journal-title":"BMC Gastroenterol"},{"key":"1999_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MIB.0000000000000313","volume":"21","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006\u20132012: a Nationwide population-based study. Inflamm Bowel Dis. 2015;21:623\u201330.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-01999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-023-01999-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-01999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:05:52Z","timestamp":1687957552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-023-01999-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s00535-023-01999-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kyung-Ah Kim, Hwa Young Choi, Moran Ki, Eun Sun Jang, and Sook-Hyang Jeong declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The requirement for written informed consent was waived by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent in studies with human subjects"}}]}}